SHShengqiang Hu

Shengqiang Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shengqiang Hu has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Tumor Microenvironment-Triggered Calcium Ion and Hydroxyl Radical Amplifier with Near-Infrared Absorption for Photoacoustic Imaging-Guided Calcium Overload-Synergized Multimodal Cancer Therapy

    by Yuzhen Ma, Caiying Li, Min He, Lixian Huang, Fanggui Ye, Jingjin Zhao, Shengqiang Hu, Shulin Zhao

    Calcium overload therapy represents a highly promising therapeutic strategy and has attracted extensive attention in the field of tumor treatment. Nevertheless, the challenge of achieving high-concentration and precise enrichment of calcium ions inside tumors seriously hinders the clinical translation of this therapy. Moreover, monotherapy fails to deliver superior anti-tumor efficacy. To address such issues, a tumor microenvironment (TME)-triggered calcium ion and hydroxyl radical amplifier with near-infrared absorption (CuMPB@CaCO3@HA) is presented to process calcium overload-synergized multimodal combination therapy. It can bind to the CD44 receptor on the surface of cancer cells, thereby accumulating in tumor tissues, where it is decomposed by the TME to release Ca2+ and copper-doped mesoporous Prussian blue (CuMPB). The released Ca2+ triggers intracellular calcium overload. The released CuMPB has a characteristic absorption peak in the range of 650–900 nm, which enables photoacoustic (PA) imaging and photothermal therapy of the tumor. In addition, Cu2+ in CuMPB undergoes a cascade reaction with highly abundant glutathione and H2O2 in the TME, producing hydroxyl radicals (·OH); additionally, the Fe2+ ion in MPB also undergoes a Fenton reaction with H2O2 to generate ·OH, achieving highly efficient chemodynamic therapy (CDT). Moreover, laser irradiation promotes the generation of ·OH, thereby further enhancing CDT. Both in vitro and in vivo experiments verified that CuMPB@CaCO3@HA enables in situ PA diagnosis of tumors to visualize tumor accumulation and optimize the treatment window and enables PA imaging-guided synergistic calcium overload-chemodynamic-photothermal antitumor therapy based on TME characteristics, thus providing a new strategy for the development of tumor-targeted nanotheranostic agents, highlighting the untapped potential of nanoassembly.

  • Photoacoustic Probe for Rapidly Recognizing Superoxide Anion Affording Visualized Tracing of Ferroptosis-Mediated Acute Liver Injury

    by Yidong Bin, Lixian Huang, Caiying Li, Jingjin Zhao, Shengqiang Hu, Shulin Zhao, Yong Huang, Liangliang Zhang

    As an emerging form of regulated cell death, ferroptosis has been identified as a key contributor to the pathogenesis of several diseases. Superoxide anion (O2•–), a key reactive oxygen species, is closely associated with ferroptosis-mediated acute liver injury (ALI). The development of in situ, real-time imaging tools capable of visualizing O2•– will benefit the early diagnosis and therapeutic intervention of ferroptosis-mediated ALI. In this work, we designed and synthesized a photoacoustic (PA) probe, Rho-DOH, based on a rhodamine scaffold, for the specific detection of O2•–. Rho-DOH exhibits a highly sensitive, selective, and fast PA response toward O2•–, characterized by a large bathochromic shift of 125 nm and an activation fold of up to 29-fold. Cellular experiments demonstrate that Rho-DOH enables high-contrast PA imaging of endogenous O2•– in cells. Moreover, Rho-DOH was successfully applied to detect the ferroptosis-mediated ALI and to evaluate therapeutic responses through its O2•–-responsive PA imaging signal. These findings position Rho-DOH as a promising molecular imaging tool, offering robust support for the accurate diagnosis and treatment of ferroptosis-associated liver injury.

  • Cell Probe Cocktail Enables Ratiometric miRNA Detection with Enhanced Sensitivity and an Extended Dynamic Range

    by Shengkai Zhang, Lanshuang Hu, Luyin Wang, Mengjiao Huang, Liangliang Zhang, Shulin Zhao, Shengqiang Hu

    Sensitive and wide-range detection of miRNA is crucial for monitoring early stage and progressive diseases. However, achieving both high sensitivity and a broad response range in a single sensing platform remains challenging due to the inherent trade-off between these properties. In this study, we develop a novel cell probe cocktail integrated with nicking endonuclease-assisted strand displacement amplification (SDA) for the ratiometric detection of miRNA, enabling concurrent enhancement of sensitivity and expansion of the dynamic range. The counting probes were constructed by conjugating suspended cells with aptamer-functionalized magnetic nanoparticles. A cell probe cocktail system was thus created by combining two types of these counting probes. Leveraging the programmability of DNA, target recognition-induced conformational changes enable the regulation of cell probe assembly and disassembly by modulating the binding of aptamers to cell surface receptors, thereby yielding sensitive, wide-dynamic-range ratiometric readouts. As a proof of concept, ratiometric detection of miRNA-21 over a concentration range of 0.2-100 nM was successfully achieved, with a limit of detection (LOD) of 0.038 nM. The inherent programmability of DNA underscores the versatility of this cell probe cocktail strategy, enabling adaptive sensing across diverse DNA-based architectures.

  • Integrated Enzyme-Powered DNA-Gold Nanomachine for In Vivo Amplified mRNA Photoacoustic Imaging and Enhanced Tumor Photothermal Therapy

    by Mingzhu Fan, Huiping Liang, Yifang He, Ming Shi, Jiayao Xu, Haiyan Shu, Shulong Wang, Mengjiao Huang, Shengqiang Hu, Liangliang Zhang, et al.

    Developing activatable nanotheranostics that can improve diagnostic and therapeutic performances and reduce side effects is highly attractive for precision cancer medicine but remains a daunting challenge. Herein, we develop an integrated enzyme-powered DNA-gold nanomachine (DGNM@CM) for the simultaneous amplification of in vivo mRNA photoacoustic (PA) imaging and tumor-specific photothermal therapy (PTT). The DGNM@CM consists of a gold nanoparticle (AuNP) core, an interlayer of linker DNA and partially complementary DNA duplex, which is bound to aptamer-inhibited DNA polymerase, and an outer layer of the tumor cell membrane (CM). Once specifically internalized by target tumor cells, the tumor-related mRNA target interacts with DGNM@CM, initiating a strand-displacement reaction and releasing an active DNA polymerase. This reaction induces the aggregation of AuNPs, which shift their absorption from the visible to near-infrared region, thereby simultaneously activating PA imaging and PTT. More importantly, the released active DNA polymerase can catalyze the recycling of target mRNA through cyclic strand-displacement polymerization reaction and induce the continuous aggregation of AuNPs, thus realizing significant amplification of both PA imaging signals and PTT efficacy. This DGNM@CM can accurately diagnose tumors in vivo and impressively suppress tumor growth with negligible toxicity. The developed DGNM@CM can be extended for the amplified PA detection of other biomolecules and the activation of therapy by them by changing corresponding DNA sequences, thus possessing broad application prospects in biosensing, bioimaging, and precision disease theranostics.


  • A Target-Induced In Situ J-Aggregation Coupling Cascade Catalyzing Reactive Oxygen Species Clearance Strategy for 3D NIR-II Photoacoustic Imaging Diagnosis and Smart Therapy of Acute Kidney Injury

    by Yanni Luo, Lixian Huang, Kaiji Wei, Shengqiang Hu, Jinzhe Liang, Shulin Zhao

    Acute kidney injury (AKI) is a prevalent complication among hospitalized patients and is characterized by high mortality rates. Despite advancements in treatment strategies, early diagnosis and effective management of AKI remain significant challenges in clinical medicine. Herein, we present a target-induced in situ J-aggregation coupling cascade catalyzing reactive oxygen species (ROS) clearance strategy and developed a nanodiagnostic-therapeutic agent Cu-POW@Apt-CY@SC (CPACSC) for 3D near-infrared II (NIR-II) photoacoustic (PA) imaging diagnosis and smart therapy of AKI. Upon intravenous administration, CPACSC targets renal tubular epithelial cells via interaction with kidney injury molecule-1 (Kim-1), then binds to neutrophil gelatinase-associated lipid carrier protein (NGAL), releasing CY-1005 molecules and undergo in situ NIR-II J-aggregation, affording precise 3D multispectral PA imaging diagnosis of AKI. CPACSC exhibits also superoxide dismutase (SOD) and catalase (CAT) activities, an in situ cascade catalyzing the conversion of O2•- and H2O2 into O2, thereby cleaning up ROS in injured renal tissues and affording targeted therapy. These findings underscore CPACSC as a nanodiagnosis and treatment integrated platform for AKI, achieving precision medicine through target-induced in situ NIR-II J-aggregation and cascade catalyzing ROS clearance, thereby offering a strategy for AKI disease management.


  • Single-Cell Multiplexed Signal Amplification Strategy Based on Catalytic Hairpin Self-Assembly and CRISPR/Cas12a for Exploring the Relationship between lncRNA HOTAIR and miRNA-122 in Individual Hepatocytes

    by Ruiyan Li, Yuhai Chen, Rongxiang Pan, Shengqiang Hu, Shulin Zhao, Jianniao Tian, Jingjin Zhao

    The long noncoding RNA (lncRNA) HOTAIR has been shown to act as an oncogene in a variety of cancers, including hepatocellular carcinoma (HCC). MicroRNA-122 (miR-122) is a key liver-specific miRNA that is frequently inhibited in HCC and is associated with poor prognosis. However, a potential relationship between HOTAIR and miR-122 in individual hepatocytes has not been explored. To this end, we propose here an intracellular catalytic hairpin self-assembly-CRISPR/Cas12a tandem multiplexed signal amplification strategy for the simultaneous quantification of HOTAIR and miRNA-122 in a single hepatocyte. We applied this method to analyze both normal HL-7702 liver cells and HepG2 HCC cells, and found that HL-7702 cells contained large amounts of miRNA-122, while the content of miRNA-122 in HepG2 cells was low. However, the level of HOTAIR in HepG2 cells was much higher than that in HL-7702 cells, confirming the overexpression of HOTAIR in HCC cells. We achieved the simultaneous absolute quantification of HOTAIR and miRNA-122 in single cells, providing an important method to study the relationships between these two RNA molecules in individual cells.


  • Proximity-Induced Bipedal DNA Walker for Accurately Visualizing microRNA in Living Cancer Cell

    by Xiyuan Feng, Xiaofeng Bi, Jinyue Feng, Shengqiang Hu, Yumin Wang, Shulin Zhao, Liangliang Zhang

    DNA walker, a type of dynamic DNA device that is capable of moving progressively along prescribed walking tracks, has emerged as an ideal and powerful tool for biosensing and bioimaging. However, most of the reported three-dimensional (3D) DNA walker were merely designed for the detection of a single target, and they were not capable of achieving universal applicability. Herein, we reported for the first time the development of a proximity-induced 3D bipedal DNA walker for imaging of low abundance biomolecules. As a proof of concept, miRNA-34a, a biomarker of breast cancer, is chosen as the model system to demonstrate this approach. In our design, the 3D bipedal DNA walker can be generated only by the specific recognition of two proximity probes for miRNA-34a. Meanwhile, it stochastically and autonomously traveled on 3D tracks (gold nanoparticles) via catalytic hairpin assembly (CHA), resulting in the amplified fluorescence signal. In comparison with some conventional DNA walkers that were utilized for living cell imaging, the 3D DNA walkers induced by proximity ligation assay can greatly improve and ensure the high selectivity of bioanalysis. By taking advantage of these unique features, the proximity-induced 3D bipedal DNA walker successfully realizes accurate and effective monitoring of target miRNA-34a expression levels in living cells, affording a universal, valuable, and promising platform for low-abundance cancer biomarker detection and accurate identification of cancer.


  • Doping Engineering To Modulate Surface Plasmon Resonance and Enzyme-like Activities for Enhancing Photoacoustic Imaging-Guided Targeted Cancer Therapy in the Second Near-Infrared Window

    by Yanni Luo, Shulong Wang, Jingjin Zhao, Fanggui Ye, Shulin Zhao, Shengqiang Hu, Liangliang Zhang

    Biological imaging-guided targeted tumor therapy has been a soughtafter goal in the field of cancer diagnosis and treatment. To this end, we proposed a strategy to modulate surface plasmon resonance and endow WO3-x nanoparticles (NPs) with enzyme-like catalytic properties by doping Fe2+ in the structure of the NPs. Doping of the Fe2+ introduced oxygen vacancies into the structure of the NPs, inducing a red shift of the maximum absorption wavelength into the near-infrared II (NIR-II) region and enhancing the photoacoustic (PA) and photothermal properties of the NPs for more effective imaging-guided cancer therapy. Under NIR-II laser irradiation, the Fe-WO3-x NPs produced very strong NIR-II PA and photothermal effects, which significantly enhanced the PA imaging and photothermal treatment effects. On the other hand, Fe2+ in Fe-WO3-x could undergo Fenton reactions with H2O2 in the tumor tissue to generate ·OH for chemodynamic therapy. In addition, Fe-WO3-x can also catalyze the above reactions to produce more reactive oxygen species (ROS) and induce the oxidation of NADH to interfere with intracellular adenosine triphosphate (ATP) synthesis, thereby further improving the efficiency of cancer therapy. Specific imaging of tumor tissue and targeted synergistic therapy was achieved after ligation of a MUC1 aptamer to the surface of the Fe-WO3-x NPs by the complexing of -COOH in MUC1 with tungsten ions on the surface of the NPs. These results demonstrated that Fe-WO3-x NPs could be a promising diagnosis and therapeutic agent for cancer. Such a study opens up new avenues into the rational design of nanodiagnosis and treatment agents for NIR-II PA imaging and cancer therapy.


  • Acid-Triggered Degradation of Three-In-One Ag2S Quantum Dots for In Situ Ratiometric NIR-II Fluorescence Imaging-Guided Ion/Gas Combination Therapy

    by Xiaolan Tang, Zhihong Zhou, Liuyan Zhou, Yong Huang, Liangliang Zhang, Shulin Zhao, Shengqiang Hu

    Smart theranostic nanoprobes with the integration of multiple therapeutic modalities are preferred for precise diagnosis and efficient therapy of tumors. However, it remains a big challenge to arrange the imaging and two or more kinds of therapeutic agents without weakening the intended performances. In addition, most existing fluorescence (FL) imaging agents suffer from low spatiotemporal resolution due to the short emission wavelength (2S quantum dot (QD)-based smart theranostic nanoprobes were proposed for in situ ratiometric NIR-II FL imaging-guided ion/gas combination therapy of tumors. Under the acidic tumor microenvironment, three-in-one Ag2S QDs underwent destructive degradation, generating toxic Ag+ and H2S. Meanwhile, their FL emission at 1270 nm was weakened. Upon introduction of a downconversion nanoparticle (DCNP) as the delivery carrier and NIR-II FL reference signal unit, the formed Ag2S QD-based theranostic nanoprobes could achieve precise diagnosis of tumors through ratiometric NIR-II FL signals. Also, the generated Ag+ and H2S enabled specific ion/gas combination therapy toward tumors. By combining the imaging and therapeutic functions, three-in-one Ag2S QDs may open a simple yet reliable avenue to design theranostic nanoprobes.